The BPC-157 + GHK-Cu stack combines two of the most researched regenerative peptides for comprehensive tissue repair and skin rejuvenation. BPC-157 promotes angiogenesis, upregulates growth factors (VEGF, EGF, FGF), and accelerates wound healing from the inside out. GHK-Cu (Glycyl-L-Histidyl-L-Lysine Copper Complex) is a naturally occurring tripeptide that stimulates collagen synthesis, glycosaminoglycan production, and tissue remodeling while providing potent antioxidant protection. Together, BPC-157 drives new blood vessel formation while GHK-Cu rebuilds the extracellular matrix and enhances skin quality.
BPC-157 is a pentadecapeptide derived from human gastric juice that promotes tissue healing through angiogenesis (new blood vessel formation), upregulation of VEGF, EGF, and FGF growth factors, and nitric oxide modulation. It creates the vascular infrastructure needed to deliver nutrients and building materials to damaged tissue.
GHK-Cu is a copper-binding tripeptide that naturally declines with age. It stimulates collagen I, III, and V synthesis, elastin production, and glycosaminoglycan formation. While BPC-157 builds the vascular highway, GHK-Cu provides the structural materials for tissue remodeling. GHK-Cu also attracts stem cells and reduces oxidative damage at repair sites.
| Protocol | Compound 1 | Compound 2 | Timing | Duration |
|---|---|---|---|---|
| Standard | BPC-157 250mcg/day SubQ | GHK-Cu 200mcg/day SubQ | AM | 6-8 weeks |
| Enhanced | BPC-157 500mcg/day SubQ | GHK-Cu 400mcg/day SubQ | AM + PM split | 8-12 weeks |
| Topical Combo | BPC-157 250mcg/day SubQ | GHK-Cu cream 2x/day topical | AM + PM | 8 weeks |
Both compounds have excellent safety profiles with minimal adverse effects at standard doses.
| Panel | Markers | Timing |
|---|---|---|
| Inflammatory | CRP, ESR | Baseline, Week 4, Week 8 |
| Basic | CBC, CMP | Baseline, Week 6 |
| Copper | Serum copper, ceruloplasmin | Baseline, Week 6 (if concerned) |
Monitor inflammatory markers to track healing. Check copper levels if using high-dose GHK-Cu for extended periods.

They should be administered as separate injections near the target area. Do not mix in the same syringe as copper from GHK-Cu may interact with BPC-157 peptide bonds. Inject sequentially at slightly different sites.
Injectable GHK-Cu provides systemic and deep tissue effects, while topical targets skin surface. For tissue healing, SubQ near the target is preferred. For anti-aging skin, combining SubQ BPC-157 with topical GHK-Cu cream works well.
BPC-157 creates new blood vessels and upregulates growth factors at injury sites, while GHK-Cu stimulates collagen and elastin synthesis for structural repair. Together they provide both vascular support and building materials for complete tissue regeneration and skin rejuvenation.
They should be administered as separate injections near the target area. Do not mix in the same syringe as copper from GHK-Cu may interact with BPC-157 peptide bonds. Inject sequentially at slightly different sites.
Injectable GHK-Cu provides systemic and deep tissue effects, while topical targets skin surface. For tissue healing, SubQ near the target is preferred. For anti-aging skin, combining SubQ BPC-157 with topical GHK-Cu cream works well.
BPC-157 creates new blood vessels and upregulates growth factors at injury sites, while GHK-Cu stimulates collagen and elastin synthesis for structural repair. Together they provide both vascular support and building materials for complete tissue regeneration and skin rejuvenation.
They should be administered as separate injections near the target area. Do not mix in the same syringe as copper from GHK-Cu may interact with BPC-157 peptide bonds. Inject sequentially at slightly different sites.
Injectable GHK-Cu provides systemic and deep tissue effects, while topical targets skin surface. For tissue healing, SubQ near the target is preferred. For anti-aging skin, combining SubQ BPC-157 with topical GHK-Cu cream works well.